JHVEPhoto/iStock Editorial via Getty Images McKesson ( NYSE: MCK ), Cardinal Health ( NYSE: CAH ), and Cencora ( NYSE: COR ) are said to be interested in acquiring privately-held Florida Cancer Specialists & Research Institute. Bloomberg reported that the cancer clinic operator could be worth up to $3B . It has 250 physicians, 280 nurse practitioners and physician assistants, and about 100 locations.
Florida Cancer Specialists embraces the value-based care model where it is reimbursed via a lump sum to treat a patient rather than per test or visit. In this way, the provider is incentivized to provide the best, most efficient treatment plan. Cancer care has enticed drug distributors recently as a way to boost distribution of specialty drugs.
More on Cardinal, Cencora, McKesson McKesson Corporation: An Interesting Health Giant With A Hidden Gem Cardinal Health: Growing Into The Valuation Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning CVS, Cencora drop as Walgreens announces store closures Cencora reportedly notifying about cyberattack.